Deletion of the monkeypox virus inhibitor of complement enzymes locus impacts the adaptive immune response to monkeypox virus in a nonhuman primate model of infection

Journal of Virology

Volumn 85, Issue 18, 2011, Pages 9527-9542

  Estep, Ryan D ^a   Messaoudi, Ilhem ^a,b   O'Connor, Megan A ^a   Li, Helen ^a   Sprague, Jerald ^a   Barron, Alexander ^a   Engelmann, Flora ^a   Yen, Bonnie ^a   Powers, Michael F ^a   Jones, John M ^a   Robinson, Bridget A ^a   Orzechowska, Beata U ^a   Manoharan, Minsha ^a   Legasse, Alfred ^b   Planer, Shannon ^b   Wilk, Jennifer ^b   Axthelm, Michael K ^a,b   Wong, Scott W ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONKEYPOX INHIBITOR OF COMPLEMENT ENZYME; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BLOOD ANALYSIS; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE DELETION; IN VIVO STUDY; LUNG PARENCHYMA; MALE; MONKEYPOX; MONKEYPOX VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ADAPTIVE IMMUNITY; ANIMALS; B-LYMPHOCYTES; BLOOD; DISEASE MODELS, ANIMAL; DNA, VIRAL; FEMALE; GENE DELETION; LUNG; MACACA MULATTA; MALE; MOLECULAR SEQUENCE DATA; MONKEYPOX; MONKEYPOX VIRUS; PRIMATE DISEASES; SEQUENCE ANALYSIS, DNA; SKIN; T-LYMPHOCYTES; VIRAL PROTEINS; VIRULENCE FACTORS;

MACACA MULATTA; MONKEYPOX VIRUS; ORTHOPOXVIRUS; PRIMATES; VARIOLA VIRUS;

EID: 80052480937     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00199-11     Document Type: Article

References (38)

1. Amanna, I. J., M. K. Slifka, and S. Crotty.2006. Immunity and immunological memory following smallpox vaccination. Immunol. Rev. 211:320-337.
2. Blackburn, S. D., et al.2009. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 10:29-37.
3. Breman, J. G., et al. 1980. Human monkeypox, 1970-79. Bull. World Health Organ. 58:165-182.
4. Brodie, R., A. J. Smith, R. L. Roper, V. Tcherepanov, and C. Upton.2004. Base-By-Base: single nucleotide-level analysis of whole viral genome alignments. BMC Bioinformatics 5:96.
5. Cameron, C. M., J. W. Barrett, M. Mann, A. Lucas, and G. McFadden.2005. Myxoma virus M128L is expressed as a cell surface CD47-like virulence factor that contributes to the downregulation of macrophage activation in vivo. Virology 337:55-67.
6. Carroll, M. C.2004. The complement system in regulation of adaptive immunity. Nat. Immunol. 5:981-986.
7. Chen, N., et al.2005. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology 340:46-63.
8. Ciulla, E., A. Emery, D. Konz, and J. Krushkal.2005. Evolutionary history of orthopoxvirus proteins similar to human complement regulators. Gene 355:40-47.
9. Di Giulio, D. B., and P. B. Eckburg.2004. Human monkeypox: an emerging zoonosis. Lancet Infect. Dis. 4:15-25.
10. Girgis, N. M., et al.2011. The vaccinia virus complement control protein modulates adaptive immune responses during infection. J. Virol. 85:2547- 2556.
11. Hammarlund, E., et al.2003. Duration of antiviral immunity after smallpox vaccination. Nat. Med. 9:1131-1137.
12. Heymann, D. L., M. Szczeniowski, and K. Esteves. 1998. Re-emergence of monkeypox in Africa: a review of the past six years. Br. Med. Bull. 54:693- 702.
13. Hutin, Y. J., et al.2001. Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg. Infect. Dis. 7:434-438.
14. Hutson, C. L., et al.2009. A prairie dog animal model of systemic orthopoxvirus disease using West African and Congo Basin strains of monkeypox virus. J. Gen. Virol. 90:323-333.
15. Isaacs, S. N., G. J. Kotwal, and B. Moss. 1992. Vaccinia virus complementcontrol protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc. Natl. Acad. Sci. U. S. A. 89:628-632.
16. Johnson, R. F., et al.2011. Comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route. J. Virol. 85:2112-2125.
17. Khodakevich, L., Z. Jezek, and D. Messinger. 1988. Monkeypox virus: ecology and public health significance. Bull. World Health Organ. 66:747-752.
18. Khodakevich, L., et al. 1987. The role of squirrels in sustaining monkeypox virus transmission. Trop. Geogr. Med. 39:115-122.
19. Kohl, J., and M. Wills-Karp.2007. Complement regulates inhalation tolerance at the dendritic cell/T cell interface. Mol. Immunol. 44:44-56.
20. Lambris, J. D., D. Ricklin, and B. V. Geisbrecht.2008. Complement evasion by human pathogens. Nat. Rev. Microbiol. 6:132-142.
21. Likos, A. M., et al.2005. A tale of two clades: monkeypox viruses. J. Gen. Virol. 86:2661-2672.
22. Liszewski, M. K., et al.2006. Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation. J. Immunol. 176:3725-3734.
23. Manes, N. P., et al.2008. Comparative proteomics of human monkeypox and vaccinia intracellular mature and extracellular enveloped virions. J. Proteome Res. 7:960-968.
24. Markiewski, M. M., et al.2008. Modulation of the antitumor immune response by complement. Nat. Immunol. 9:1225-1235.
25. Messaoudi, I., et al.2009. Simian varicella virus infection of rhesus macaques recapitulates essential features of varicella zoster virus infection in humans. PLoS Pathog. 5:e1000657.
26. Miller, C. G., S. N. Shchelkunov, and G. J. Kotwal. 1997. The cowpox virus-encoded homolog of the vaccinia virus complement control protein is an inflammation modulatory protein. Virology 229:126-133.
27. Pitcher, C. J., et al.2002. Development and homeostasis of T cell memory in rhesus macaque. J. Immunol. 168:29-43.
28. Reed, K. D., et al.2004. The detection of monkeypox in humans in the Western Hemisphere. N. Engl. J. Med. 350:342-350.
29. Saijo, M., et al.2009. Virulence and pathophysiology of the Congo Basin and West African strains of monkeypox virus in non-human primates. J. Gen. Virol. 90:2266-2271.
30. Sbrana, E., S. Y. Xiao, P. C. Newman, and R. B. Tesh.2007. Comparative pathology of North American and central African strains of monkeypox virus in a ground squirrel model of the disease. Am. J. Trop. Med. Hyg. 76:155- 164.
31. Shchelkunov, S. N.2003. Immunomodulatory proteins of orthopoxviruses. Mol. Biol. 37:37-48. (In Russian.)
32. Shchelkunov, S. N., et al.2002. Analysis of the monkeypox virus genome. Virology 297:172-194.
33. Stittelaar, K. J., et al.2005. Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus. J. Virol. 79: 7845-7851.
34. Tcherepanov, V., A. Ehlers, and C. Upton.2006. Genome Annotation Transfer Utility (GATU): rapid annotation of viral genomes using a closely related reference genome. BMC Genomics 7:150.
35. Upton, C., D. Hogg, D. Perrin, M. Boone, and N. L. Harris.2000. Viral genome organizer: a system for analyzing complete viral genomes. Virus Res. 70:55-64.
36. Weaver, J. R., and S. N. Isaacs.2008. Monkeypox virus and insights into its immunomodulatory proteins. Immunol. Rev. 225:96-113.
37. Wills-Karp, M.2007. Complement activation pathways: a bridge between innate and adaptive immune responses in asthma. Proc. Am. Thorac. Soc. 4:247-251.
38. Zaucha, G. M., P. B. Jahrling, T. W. Geisbert, J. R. Swearengen, and L. Hensley.2001. The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis). Lab. Invest. 81: 1581-1600.